Skip to content

HORIZONH2020

Fundacao Gimm - Gulbenkian Institute for Molecular Medicine

Country
PTPortugal
Defence projects
0
Projects, all programmes
50
As coordinator
21
EU contribution (CORDIS)
EUR 38,406,380
Active
2018 to 2026

Projects

50 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
iMM-CAREiMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETYHORIZON2023CoordinatorEUR 13,000,000
RT-SuperESReal-Time high-content Super-Resolution Imaging of ES Cell StatesHORIZON2023ParticipantEUR 8,475
METHYLOMICDNA methylation markers to predict treatment success of biologicals in Crohn’s disease.HORIZON2023ParticipantEUR 456,250
PASSAGEPlasmodium liver stage schizogony: high replication and genetic diversityHORIZON2023CoordinatorEUR 2,467,196
CarrerasLeadersCarreras Postdoc Program Empowering Future Leaders to Fight Blood CancersHORIZON2023Associated partnerEUR 0
GEREMYGene Therapy for treatment of rare inherited Arrhythmogenic CardiomyopathyHORIZON2023ParticipantEUR 507,890
Aqua-SynapseThe health benefits of deuterium depletion on synaptic function, regional metabolism, and behaviourHORIZON2023ParticipantEUR 239,200
MusclePlateHuman skeletal muscle platform for disease modelling and high-throughput drug screeningHORIZON2023CoordinatorEUR 150,000
OptiViVaxOptimising a High Efficacy Plasmodium vivax Malaria VaccineHORIZON2023ParticipantEUR 496,471
SweetEggsThe impact of germline metabolic reprogramming on reproduction and physiologyHORIZON2023CoordinatorEUR 1,481,513
STRATA-FITStratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies for difFIcult-to-Treat diseaseHORIZON2023ParticipantEUR 907,186
HCMSpliceAOCMolecular design and application of splice-switching antibody-oligonucleotide conjugate for hypertrophic cardiomyopathy-related MYBPC3 splice modulation.HORIZON2023CoordinatorEUR 156,779
SynEryBottom-up reconstruction of a Synthetic ErythrocyteHORIZON2022ParticipantEUR 357,598
END-VOCENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOCHORIZON2022ParticipantEUR 453,658
miRToTALLA microRNA-regulated cell death-inducing gene therapy for T-cell Acute Lymphoblastic LeukemiaHORIZON2022CoordinatorEUR 150,000
RAISEResearchers in Action for Inclusion in Science and EducationHORIZON2022ParticipantEUR 16,120
CANCERNARNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPYHORIZON2022ParticipantEUR 550,625
ISIDOReIntegrated Services for Infectious Disease Outbreak ResearchHORIZON2022ParticipantEUR 4,004
BRAINTEASERBRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosisH20202021ParticipantEUR 362,565
ENLIGHT-TENplusEuropean Network Linking Informatics and Genomics of Helper T cells in TissuesH20202021ParticipantEUR 237,720

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.